Neogenomics (NEO) Issues Q2 Earnings Guidance

Share on StockTwits

Neogenomics (NYSE:NEO) updated its second quarter earnings guidance on Wednesday. The company provided EPS guidance of $0.00-0.01 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.00, AnalystRatings.NET reports. The company issued revenue guidance of $18.8-19.3 million, compared to the consensus revenue estimate of $17.27 million.

On a related note, analysts at Stephens initiated coverage on shares of Neogenomics in a research note on Friday, February 14th. They set an overweight rating and a $6.00 price target on the stock. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. The company currently has an average rating of Buy and a consensus price target of $6.50.

Neogenomics (NYSE:NEO) opened at 3.48 on Wednesday. Neogenomics has a 52 week low of $2.05 and a 52 week high of $4.69. The stock’s 50-day moving average is $3.43 and its 200-day moving average is $3.59. The company has a market cap of $170.9 million and a price-to-earnings ratio of 86.25.

Neogenomics (NYSE:NEO) last released its earnings data on Wednesday, February 19th. The company reported $0.04 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.02 by $0.02. The company had revenue of $18.30 million for the quarter, compared to the consensus estimate of $17.80 million. On average, analysts predict that Neogenomics will post $0.01 earnings per share for the current fiscal year.

NeoGenomics, Inc (NYSE:NEO) operates a network of cancer-focused testing laboratories.

Receive News & Ratings for Neogenomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogenomics and related companies with Analyst Ratings Network's FREE daily email newsletter.

Latest News

American Midstream Partners Sees Large Volume Increase After Dividend Announcement
American Midstream Partners Sees Large Volume Increase After Dividend Announcement
Align Technology Sees Large Volume Increase on Strong Earnings
Align Technology Sees Large Volume Increase on Strong Earnings
Olin Stock Price Down 3.9% Following Weak Earnings
Olin Stock Price Down 3.9% Following Weak Earnings
Short Interest in Orbitz Worldwide Rises By 50.9%
Short Interest in Orbitz Worldwide Rises By 50.9%
Banco Bradesco SA Trading 4.5% Higher  After Dividend Announcement
Banco Bradesco SA Trading 4.5% Higher After Dividend Announcement
Short Interest in Hemispherx BioPharma Grows By 19.0%
Short Interest in Hemispherx BioPharma Grows By 19.0%


Leave a Reply

 
Advertisement
Advertisement
© 2006-2014 Mideast Time.